Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Thermo Fisher Diagnostics ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.3% 1.3%   Bankruptcy risk   1.9% 2.0% 1.9% 1.9% 0.4% 0.6% 4.7% 4.4%   Credit score (0-100)   71 71 70 68 100 96 45 47   Credit rating   A A A A AAA AA BBB BBB   Credit limit (kDKK)   6.5 6.6 10.9 9.0 7,252.0 6,991.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 0.0 0.0 44,114 31,409 0.0 0.0   EBITDA   10,532 10,028 6,791 1,745 20,408 11,090 0.0 0.0   EBIT   10,532 10,028 6,791 1,745 16,774 7,468 0.0 0.0   Pre-tax profit (PTP)   8,395.0 7,544.0 5,002.0 1,165.0 16,112.0 8,449.0 0.0 0.0   Net earnings   8,395.0 7,544.0 5,002.0 1,165.0 12,562.0 6,600.0 0.0 0.0   Pre-tax profit without non-rec. items   10,532 10,028 6,791 1,745 16,112 8,449 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 4,091 3,236 0.0 0.0   Shareholders equity total   30,118 37,662 42,664 43,893 56,455 63,055 62,930 62,930   Interest-bearing liabilities   0.0 0.0 0.0 0.0 18,246 55,149 0.0 0.0   Balance sheet total (assets)   115,243 84,458 77,865 116,081 92,727 130,040 62,930 62,930   Net Debt   0.0 0.0 0.0 0.0 18,246 55,149 -55,074 -55,074     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 0.0 0.0 44,114 31,409 0.0 0.0   Gross profit growth   -100.0% 0.0% 0.0% 0.0% 0.0% -28.8% -100.0% 0.0%   Employees   27 31 35 31 28 24 0 0   Employee growth %   22.7% 14.8% 12.9% -11.4% -9.7% -14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   115,243 84,458 77,865 116,081 92,727 130,040 62,930 62,930   Balance sheet change%   143.1% -26.7% -7.8% 49.1% -20.1% 40.2% -51.6% 0.0%   Added value   10,532.0 10,028.0 6,791.0 1,745.0 16,774.0 11,090.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -25,121 0 0 0 10,731 -6,895 -3,236 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 0.0% 0.0% 38.0% 23.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.0% 10.0% 8.4% 1.8% 16.1% 9.3% 0.0% 0.0%   ROI %   13.8% 10.0% 8.4% 1.8% 17.5% 10.5% 0.0% 0.0%   ROE %   32.4% 22.3% 12.5% 2.7% 25.0% 11.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 100.0% 60.9% 48.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% 89.4% 497.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 32.3% 87.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 7.5% 5.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 2.2 1.8 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 0.0 0.0 43,552.0 53,651.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   390 323 194 56 599 462 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   390 323 194 56 729 462 0 0   EBIT / employee   390 323 194 56 599 311 0 0   Net earnings / employee   311 243 143 38 449 275 0 0